Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation

被引:24
|
作者
Ashton, JC [1 ]
Zheng, YW [1 ]
Liu, P [1 ]
Darlington, CL [1 ]
Smith, PF [1 ]
机构
[1] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand
关键词
CB1; receptor; unilateral vestibular deafferentation; vestibular nucleus complex;
D O I
10.1016/j.brainres.2004.06.065
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CB1 receptor expression has been reported to be low in the brainstem compared with the forebrain, and low in the vestibular nucleus complex (VNC) compared with other regions in the brainstem. However, a frequent effect of cannabis is dizziness and loss of balance. This may be due to the activation of cannabinoid receptors in the central vestibular pathways. We used immunohistochemistry to study the distribution of CB1 receptor protein in the VNC, and Western blotting to measure CB 1 receptor expression in the VNC following unilateral vestibular deafferentation (UVD); the hippocampal CA1, CA2/3 and dentate gyrus (DG) regions were also analysed for comparison. This study confirms a previous electrophysiological demonstration that CB1 receptors exist in significant densities in the VNC and are likely to contribute to the neurochemical control of the vestibular reflexes. Nonetheless, CB1 receptor expression did not change significantly in the VNC during vestibular compensation. In addition, despite some small but significant changes in CB1 receptor expression in the CA2/3 and the DG following UVD, in no case were these differences statistically significant in comparison to both control groups. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 43 条
  • [21] Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model
    Ranjbar, Hoda
    Soti, Monavareh
    Janahmadi, Mahyar
    Kohlmeier, Kristi A.
    Sheibani, Vahid
    Ahmadi-Zeidabadi, Meysam
    Shabani, Mohammad
    EXPERIMENTAL BRAIN RESEARCH, 2022, 240 (09) : 2339 - 2348
  • [22] Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
    Shearman, LP
    Rosko, KM
    Fleischer, R
    Wang, J
    Xu, S
    Tong, XS
    Rocha, BA
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (08): : 573 - 582
  • [23] Pyrolysis of UR-144, a synthetic cannabinoid, augments an affinity to human CB1 receptor and cannabimimetic effects in mice
    Kaizaki-Mitsumoto, Asuka
    Hataoka, Kyoko
    Funada, Masahiko
    Odanaka, Yuki
    Kumamoto, Hiroki
    Numazawa, Satoshi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2017, 42 (03) : 335 - 341
  • [24] Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta
    T. Schultheiß
    K. Flau
    M. Kathmann
    M. Göthert
    E. Schlicker
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2005, 372 : 139 - 146
  • [25] Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease
    Silverdale, MA
    McGuire, S
    McInnes, A
    Crossman, AR
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 2001, 169 (02) : 400 - 406
  • [26] CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission
    Emilia Grzęda
    Eberhard Schlicker
    Marek Toczek
    Iwona Zalewska
    Marta Baranowska-Kuczko
    Barbara Malinowska
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 25 - 35
  • [27] The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB1 receptor in vitro
    Dhopeshwarkar, Amey S.
    Jain, Saurabh
    Liao, Chengyong
    Ghose, Sudip K.
    Bisset, Kathleen M.
    Nicholson, Russell A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 654 (01) : 26 - 32
  • [28] Novel selective cannabinoid CB1 receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects
    Chen, Wei
    Xu, Cheng
    Liu, Hong-ying
    Long, Long
    Zhang, Wei
    Zheng, Zhi-bing
    Xie, Yun-de
    Wang, Li-li
    Li, Song
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (09) : 1148 - 1158
  • [29] Novel selective cannabinoid CB1 receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects
    Wei Chen
    Cheng Xu
    Hong-ying Liu
    Long Long
    Wei Zhang
    Zhi-bing Zheng
    Yun-de Xie
    Li-li Wang
    Song Li
    Acta Pharmacologica Sinica, 2011, 32 : 1148 - 1158
  • [30] Changes in Histamine Receptors (H1, H2, and H3) Expression in Rat Medial Vestibular Nucleus and Flocculus after Unilateral Labyrinthectomy: Histamine Receptors in Vestibular Compensation
    Zhou, Liuqing
    Zhou, Wen
    Zhang, Sulin
    Liu, Bo
    Leng, Yangming
    Zhou, Renhong
    Kong, Weijia
    PLOS ONE, 2013, 8 (06):